Loading company details...
Latest Form 4 (Nov 6, 2026): Jennifer Michaelson (Chief Scientific Officer): Exercise/Conversion of 3,805 shares, $16.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 6, 2026 | Jennifer Michaelson, Chief Scientific Officer | Exercise/Conversion | 3,805 | $16.4K |
| Sep 10, 2026 | Jennifer Michaelson, Chief Scientific Officer | Exercise/Conversion | 4,000 | $17.2K |
| Aug 14, 2026 | Jennifer Michaelson, Chief Scientific Officer | Exercise/Conversion | 30,000 | $129.0K |
| Jul 7, 2026 | Jennifer Michaelson, Chief Scientific Officer | Exercise/Conversion | 4,000 | $17.2K |
| Jul 2, 2026 | Jacquelyn L. Sumer, Chief Legal Officer | Grant/Award | 2,470 | $21.2K |
| Jul 2, 2026 | Mary Kay Fenton, Chief Financial Officer | Grant/Award | 1,541 | $13.3K |
| Jun 18, 2026 | Anthony Rosenberg | Grant/Award | 25,319 | n/a |
| Jun 18, 2026 | David D. Meek | Grant/Award | 25,319 | n/a |
| Jun 18, 2026 | Stephen W. Webster | Grant/Award | 25,319 | n/a |
| Jun 18, 2026 | Andrew R. Allen | Grant/Award | 21,781 | n/a |